Skip to main content

Beauty

Analysis and advice on the fast-evolving beauty business.

A Luxury Skincare Line, Made for Younger Faces

La Prairie’s new Swiss Pristine collection, aimed at entry-level shoppers, is a big bet on how aspirational products can be.


China’s New Tourist Obsession Is a 24-Hour Spa

For less than the cost of many hotels, sprawling bathhouses offer soaking pools, sleeping lounges, lobster buffets and TikTok-ready wellness.


Inside Target’s Great Beauty Reset

This week, Priya Rao looks at the relaunch of the US mass retailer’s new shop-in-shops.


Can Estée Lauder Turn a Moment Into Momentum?

The US cosmetics giant’s stock lifted 17 percent on better-than-expected earnings, but faces challenges in its makeup and hair divisions.


Beauty Is Betting on Fragrance. Why Isn’t Shiseido?

The Japanese conglomerate has taken a conservative approach to expanding its perfume portfolio against a greater boom where global competitors supercharge their efforts.


For Teen Boys, Beauty Is Suddenly Cool

While talk of tween beauty typically centres around gourmand body sprays and skincare for girls, Gen Alpha boys are buying up luxury fragrances and TikTok-famous hair products.


How a New Zealand Toymaker Became a Beauty Challenger

The Zuru Group, which owns brands like Monday Haircare and Daise, has used its manufacturing prowess and retailer relationships to build a $1 billion business. One woman leads them all.


A Preview of Estée Lauder’s Summer Report Card

This week, the American company will report its earnings after a quarter that saw an abandoned merger, scrapped brand divestments and executive reshuffling. How will the market react?


How the Club Became a Fragrance Hall

Perfume brands are marketing their wares at nightlife spaces, where scent, intimacy and memory make for a uniquely potent pitch.


The Value of a Louis Vuitton Lipstick

This week, Priya Rao looks at private equity’s backlog, luxury’s dated beauty strategy and the ways brands hope to win over Gen Alpha.


The Controversial New Wellness Capital of the US

The Sunshine State has long been a destination for plastic surgery, but has more recently become a hub for founders and a clandestine birthplace for new policies shaping national health.


The Risky Business of Experimental Peptides

Business owners and politicians are lobbying regulators for easier access to new injectable drugs against the recommendations of some medical experts. But customer demand isn’t waning.